Latest News
Tyra Biosciences, Inc.
- Tyra Biosciences (NASDAQ:TYRA) Stock Jumps 4.4% - Here's Why
- Tyra Biosciences advances research on FGFR3-driven treatment strategies
- Avoiding Lag: Real-Time Signals in (TYRA) Movement
- Tyra Biosciences, Inc. Rings the Nasdaq Stock Market Opening Bell
- Law firm probes Tyra Biosciences over possible securities fraud after drug trial safety concerns.
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tyra Biosciences, Inc. - TYRA
- Tyra Biosciences faces investigation after adve...
- Exclusive BAC Article: Tyra Biosciences; Positive Data Dabogratinib LG-IR-NMIBC, Q1 2027 ACH Results Same Drug, Expansion LG-UTUC Data, And Catalysts (NASDAQ:TYRA)
- Raymond James reiterates Strong Buy on Tyra Biosciences stock
- Will Phase 2 Safety Concerns Change Tyra Biosciences Stock Narrative
- Bank of America Corp DE Purchases 349,732 Shares of Tyra Biosciences, Inc. $TYRA
- Equities Analysts Set Expectations for TYRA FY2026 Earnings
Headlines from the last 30 days, linking to the original publishers. See all market news →